Schedule of Warrants Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of Shares of Common Stock Issuable for Warrants, Beginning Balance | 511,333,351,090 | 54,280,658 |
| Weighted average exercise price, Beginning Balance | $ 0.00009 | $ 1.43 |
| Number of Shares of Common Stock Issuable for Warrants, issuance of warrants | ||
| Weighted average exercise price issuance of warrants | ||
| Increase in number of shares of common stock issuable under warrants during the period as a result of down round provisions | 511,312,671,643 | |
| Number of Shares of Common Stock Issuable for Warrants,expiration of warrants | (1) | (33,601,211) |
| Weighted average exercise price expiration of warrants | $ (794,998) | $ (0.9141) |
| Number of Shares of Common Stock Issuable for Warrants, Ending Balance | 511,333,351,089 | 511,333,351,090 |
| Weighted average exercise price, Ending Balance | $ 0.00009 | $ 0.00009 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options expiration warrants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Sharebased compensation arrangement by share based payment award non options issuance warrants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Sharebased compensation arrangement by sharebased payment award non options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed. No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase (decrease) in the number of shares under non-option equity instrument agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|